SPDS organises 'Disso India--Hyderabad 2018' to introduce new technology and innovation related to dissolutionRead Now
Society for Pharmaceutical Dissolution Science (SPDS) conducted its 6th Annual International Convention 'Disso India--Hyderabad 2018' on June 28 and 29, 2018 at Hotel Avasa, Hyderabad. The event promoted introduction of new technology, innovation and discussed various issues related to dissolution. The two-day event witnessed presence of several eminent professionals from the pharmaceutical industry.
Disso India is the flagship International Conference of SPDS conducted every year and is attended by professionals from Indian pharma, R&D, QA and QC as well as the academia. Disso India-Hyderabad 2018 had 18 lectures from eminent professionals from pharmaceutical industry from around the world as well as the academia. Around 250 delegates from industry and academia participated in this conference.
The conference was organised under the chairmanship of Udaya Bhaskar, Director General, Pharmexcil, Hyderabad and the organizing secretary, Dr. B.M. Rao, Vice President and Head of corporate QC, Dr. Reddy’s Labs, Hyderabad.
The scientific sessions were programmed and executed under the chairmanship of Prof. Padma V. Devarajan, Professor in Pharmacy, Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology.
The event comprised of plenary lecture, panel discussion, exhibits and poster session.
Prof. Raghuram Rao Akkinepally, director – NIPER SAS Nagar who was the chief guest of the event inaugurated the event with the lighting of the event. The scientific abstract book was released at the hands of Dr. Raghuram Rao during the event.
Disso India - Hyderabad 2018 had exceptional global speakers who presented on varied topics.
While Dr. Anant Ketkar, Sun Pharma Advanced Research Company, India gave his presentation on PBPK Modelling and Simulation: An In silico - In Vivo Bridge for Efficient Formulation Development; Dr. Chuei Wuei Leong, Founder and Principal consultant, CEXA Consultancy Sdn Bhd, Malaysia delivered his speech on Pro-drugs Challenges In Dissolution. Dr. Namita Tipnis, University of Connecticut, USA gave a presentation on Application of USP 4 in dissolution testing of complex parenterals and IVIVC.
Other speakers who delivered speech in the event included Dange Veerpaneni, President/CEO, Sparsha Pharma, Hyderabad, India on challenges and development of trans dermal patches in perspective of dissolution studies; Grove Geoffrey, Product Manager and Application Scientist, SOTAX Corporation, USA on new developments in fully automated dissolution technology; Prof. Imre Klebovich, Professor of Pharmaceutics, Semmelweis University Department of Pharmaceutics, Budapest, Hungary on tracking the effect of drug interactions with in vitro dissolution studies; Dr. Jennifer Dressman, Prof. of Pharmaceutical Technology, Institute of Pharmaceutical Technology Biocenter, Johann Wolfgang Goethe University, Germany On the future of bioequivalence: changing paradigms at the FDA; Dr. Kailas Thakker, COO & Co-founder, Tergus Pharma, USA on IVRT for topical dosage forms as BA/BE waiver; Dr. Kalyanaraman; Senior Director – AR&D, Dr. Reddy’s Laboratories Ltd, India on opportunities & practical challenges in dissolution testing of generic drugs; Rashi Kochhar, Shimadzu India on chromatography automations in the QC lab; Dr. Roger Willams, Partner, NDA Partners LLC, USA on recent drug regulation and the pharmacopoeias; Saji Thomas, Director, Par Pharmaceutical, USA on life cycle management of analytical methods; Samir Haddouchi, Managing Director, SPS Pharma Services, Orleans, France on In vitro testing for non-conventional dosage forms; Dr. Sandip Tiwari, Fellow, Manufacturing Science and Technology, Actavis Laboratories FL, Inc., Florida, USA On dissolution failures: interesting scenarios; Seema Trivedi,GM Technical; Anshul Life Sciences, India on excipients quality & trouble shooting; Prof. Umesh Banakar, Professor and President, Banakar Consulting Services, USA On predicting bioavailability from dissolution: unlocking the mystery(ies); Vijay Kshirsagar, Director and CEO, TRAC Pharma Consulting, Mumbai, India On current regulatory observations & trends related to dissolution studies; and Dr. Vinod Shah, Ex. US FDA, Pharmaceutical Consultant, USA on a science based approach to simplify regulatory pathway for a complex generics using IVRT.
SOTAX India was the platinum partner of this event. Other partners were Novartis, Electrolab, Mylan, ACG, Inveniolife, Labindia, Shimadzu, Anshul Life Sciences, Pharmexcil and USP. There were 14 selected posters which were presented during this event out of which the best 3 were awarded by Sotax India.